Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118301) titled 'The Effect of Esketamine as an Adjuvant to Ropivacaine on Rebound Pain after Nerve Block in Elderly Patients with Upper Limb Fracture: A Single-Center, Double-Blind, Randomized, Controlled Clinical Trial' on Feb. 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Wusheng County People's Hospital
Condition:
Rebound Pain
Intervention:
S group:Nerve block medications: 0.5 mg/kg esketamine + 0.35% ropivacaine, total volume 20 mL
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-20
Target Sample Size: S group:61;L group:61;
Countries of Recruitment...